SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-18-034708
Filing Date
2018-02-07
Accepted
2018-02-07 16:09:21
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3/A AMENDMENT NO. 1 TO FORM S-3 d507671ds3a.htm S-3/A 291746
2 EX-5.1 d507671dex51.htm EX-5.1 27992
3 EX-23.1 d507671dex231.htm EX-23.1 1651
4 GRAPHIC g507671g0206095449778.jpg GRAPHIC 1649
5 GRAPHIC g507671g1214073117526.jpg GRAPHIC 5105
6 GRAPHIC g507671snap0002.jpg GRAPHIC 7714
  Complete submission text file 0001193125-18-034708.txt   342773
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-222726 | Film No.: 18581201
SIC: 2834 Pharmaceutical Preparations